Covered recipient · General Payments record
MARY F VANKO
Allopathic & Osteopathic Physicians Obstetrics & Gynecology
General Payments · PY2018–2023
$4,812.33
- Reported across 149 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $269.00 | 2 |
| Food and Beverage | $190.05 | 7 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amneal Pharmaceuticals LLC | $269.00 | 2 |
| Astellas Pharma US Inc | $67.07 | 1 |
| ABBVIE INC. | $60.98 | 3 |
| Organon LLC | $27.31 | 1 |
| PFIZER INC. | $19.89 | 1 |
| Agile Therapeutics, Inc. | $14.80 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AbbVie Inc. | $17.43 | 04/19/2023 | Food and Beverage | Undisputed | 01/23/2026 | 999390329 | CMS |
| AbbVie Inc. | $21.14 | 08/17/2023 | Food and Beverage | Undisputed | 01/23/2026 | 999390333 | CMS |
| AbbVie Inc. | $22.41 | 10/04/2023 | Food and Beverage | Undisputed | 01/23/2026 | 999390339 | CMS |
| Agile Therapeutics, Inc. | $14.80 | 03/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1051459545 | CMS |
| Amneal Pharmaceuticals LLC | $91.00 | 04/08/2023 | Consulting Fee | Undisputed | 01/23/2026 | 1053543079 | CMS |
| Amneal Pharmaceuticals LLC | $178.00 | 06/06/2023 | Consulting Fee | Undisputed | 01/23/2026 | 1053543085 | CMS |
| Astellas Pharma US Inc | $67.07 | 08/29/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1034458703 | CMS |
| Organon LLC | $27.31 | 11/30/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1047036167 | CMS |
| PFIZER INC. | $19.89 | 01/17/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1049509501 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.